Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 586 AL 600

Exploring prodrug approaches for Alzheimer's treatment: an overview

Kumari P, Kumar D, Chopade S, Karati D.

Neurodegener Dis Manag. 2026 Apr;16(2):177-190. doi: 10.1080/17582024.2025.2514990. Epub 2025 Jun 26.

Alzheimer's disease basics: we all should know

Das S.

Neurol Res. 2026 Mar;48(3):330-359. doi: 10.1080/01616412.2025.2529560. Epub 2025 Jul 10.

Targeting Inflammation in Alzheimer's Disease: Insights Into Pathophysiology and Therapeutic Avenues-A Comprehensive Review

Topalis V, Voros C, Ziaka M.

J Geriatr Psychiatry Neurol. 2026 Mar;39(2):115-144. doi: 10.1177/08919887251361578. Epub 2025 Jul 23.

Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease

Majie A, Karmakar V, Ghosh A, Chakraborty S, Apurva, Layek B, Gorain B.

Biomater Adv. 2026 Jan;178:214474. doi: 10.1016/j.bioadv.2025.214474. Epub 2025 Aug 23.

The interactions of copper, glutamate, and cuproptosis: insights into brain health and Alzheimer's disease pathology

Mousavi MA, Salarvandian S, Rafiee S, Mohammadi M, Khodagholi F, Javadpour P.

Biometals. 2026 Apr;39(2):409-437. doi: 10.1007/s10534-025-00771-w. Epub 2025 Dec 1.

Dysregulated mTOR signaling in Alzheimer's disease: Linking pathogenic mechanisms to emerging therapeutic strategies

Zhang S, Wang T, Xue G, Zheng R, Ding N, Yang J, Zhang M.

J Alzheimers Dis. 2026 Jan;109(2):526-544. doi: 10.1177/13872877251400667. Epub 2025 Dec 8.

Carbon nanomaterials for tau targeting in Alzheimer's disease: Theranostic strategies and clinical prospects

Muthuramalingam K, Lee HJ.

J Alzheimers Dis. 2026 Feb;109(4):1558-1573. doi: 10.1177/13872877251407702. Epub 2025 Dec 19.

Antibody drug conjugates in Alzheimer's disease: emerging strategies and future directions

AmeliMojarad M, AmeliMojarad M.

Neuroscience. 2026 Mar 5;596:45-53. doi: 10.1016/j.neuroscience.2025.12.053. Epub 2025 Dec 20.

Guardians of homeostasis: Natural products target metabolic reprogramming in Alzheimer's disease

Zhang Z, Xu H, Zhao F, Han Z, Pan J, Li M, Guan W, Jiang P, Hao Z, Zhang Y, Ma X, Kuang H, Liu Y.

Ageing Res Rev. 2026 Jan;114:103005. doi: 10.1016/j.arr.2025.103005. Epub 2025 Dec 24.

Antimicrobial peptides inhibit Tau aggregation and modulates its pathology

Chinnathambi S, Rangappa N, Malik S.

Adv Protein Chem Struct Biol. 2026;149:375-394. doi: 10.1016/bs.apcsb.2025.09.002. Epub 2025 Oct 8.

Antibodies targeting amyloid-β and Tau oligomers in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;151:225-265. doi: 10.1016/bs.apcsb.2025.10.002. Epub 2025 Nov 5.

Paratonia in dementia: diagnosis and management strategies

Joshi S, Chutia P, Tripathi SM.

Neurodegener Dis Manag. 2026 Apr;16(2):173-176. doi: 10.1080/17582024.2025.2591413. Epub 2025 Nov 18.

Comparing clinical effect sizes of Souvenaid(TM), lecanemab, and donanemab in early Alzheimer's disease

Solfrizzi V, Imbimbo BP.

J Alzheimers Dis. 2026 Feb;109(3):1258-1263. doi: 10.1177/13872877251406221. Epub 2025 Dec 22.

Tolerability of rivastigmine transdermal patch in patients with Alzheimer's disease: a narrative review

García Ribas G, Ferrer-Picón E.

Expert Opin Drug Saf. 2026 Apr;25(4):643-655. doi: 10.1080/14740338.2025.2576520. Epub 2025 Oct 31.

Mechanistic Population Pharmacokinetic-Pharmacodynamic Model of the Tau-Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer's Disease

Pérez-Ruixo C, Li L, Galpern WR, Perez-Ruixo JJ.

Clin Pharmacol Ther. 2026 Apr;119(4):979-989. doi: 10.1002/cpt.70173. Epub 2025 Dec 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias